AstraZeneca PLC (AZN) Free Cash Flow Yield: 3.20%
Is AstraZeneca PLC’s free cash flow yield high or low?
AstraZeneca PLC's free cash flow yield of 3.20% is in line with its 5-year average of 3.11%, around the middle of its 5-year range (1.82%–4.81%).
As of Friday, June 12, 2026. 12.82% below its 12-month average of 3.67%.
AZN Free Cash Flow Yield Chart
AZN Average Free Cash Flow Yield Chart
AZN Current vs Average Free Cash Flow Yield Chart
AZN Free Cash Flow Yield Metrics
FREE CASH FLOW YIELD
3.20%
FREE CASH FLOW YIELD AVG TTM
3.67%
FREE CASH FLOW YIELD AVG 3Y
3.35%
FREE CASH FLOW YIELD AVG 5Y
3.11%
FREE CASH FLOW YIELD AVG 10Y
2.33%
FREE CASH FLOW YIELD AVG 15Y
3.69%
FREE CASH FLOW YIELD AVG 20Y
5.16%
CURRENT VS TTM AVG
-12.82%
CURRENT VS 3Y AVG
-4.42%
CURRENT VS 5Y AVG
+2.99%
CURRENT VS 10Y AVG
+37.40%
CURRENT VS 15Y AVG
-13.22%
CURRENT VS 20Y AVG
-38.02%
AZN Competitors' Free Cash Flow Yield
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AstraZeneca PLC (AZN) | $282.69B | 3.20% | 3.67% | 3.35% | 3.11% |
| Merck & Co., Inc. (MRK) | $298.29B | 4.73% | 5.83% | 5.24% | 5.04% |
| UnitedHealth Group Incorporated (UNH) | $368.30B | 5.33% | 7.01% | 5.44% | 5.29% |
| Amgen Inc. (AMGN) | $191.09B | 4.46% | 5.89% | 5.48% | 5.88% |
| Thermo Fisher Scientific Inc. (TMO) | $176.77B | 3.80% | 3.34% | 3.39% | 3.32% |
| AbbVie Inc. (ABBV) | $397.12B | 5.23% | 4.95% | 6.33% | 7.31% |
| Gilead Sciences, Inc. (GILD) | $156.28B | 6.48% | 6.07% | 7.45% | 8.69% |
| Abbott Laboratories (ABT) | $156.15B | 4.71% | 3.47% | 3.07% | 3.51% |
| Pfizer Inc. (PFE) | $149.18B | 6.33% | 7.35% | 5.93% | 7.34% |
| Intuitive Surgical, Inc. (ISRG) | $146.23B | 1.91% | 1.29% | 0.87% | 1.09% |
Yield Comparison
FCF Yield
3.20%
Earnings Yield
3.64%
Dividend Yield
1.76%
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
- Shows free cash flow after capital expenditures relative to market cap
- Can be compared with earnings yield and dividend yield
- Can be compared with the company's historical range
- Can be compared with peers that report positive free cash flow
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
AstraZeneca PLC Free Cash Flow Yield Formula & Definition
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
AstraZeneca PLC Free Cash Flow Yield FAQ
- What is the free cash flow yield for AstraZeneca PLC (AZN)?
- The free cash flow yield for AZN stock is 3.20%.
- Is AstraZeneca PLC's free cash flow yield high or low?
- AstraZeneca PLC's free cash flow yield of 3.20% is in line with its 5-year average of 3.11%, around the middle of its 5-year range (1.82%–4.81%).
- What is the TTM average free cash flow yield for AstraZeneca PLC (AZN)?
- The TTM average free cash flow yield for AZN stock is 3.67%.
- What is the 3Y average free cash flow yield for AstraZeneca PLC (AZN)?
- The 3Y average free cash flow yield for AZN stock is 3.35%.
- What is the 5Y average free cash flow yield for AstraZeneca PLC (AZN)?
- The 5Y average free cash flow yield for AZN stock is 3.11%.
- What is the 10Y average free cash flow yield for AstraZeneca PLC (AZN)?
- The 10Y average free cash flow yield for AZN stock is 2.33%.
- What is the 15Y average free cash flow yield for AstraZeneca PLC (AZN)?
- The 15Y average free cash flow yield for AZN stock is 3.69%.
- What is the 20Y average free cash flow yield for AstraZeneca PLC (AZN)?
- The 20Y average free cash flow yield for AZN stock is 5.16%.
AstraZeneca PLC Free Cash Flow Yield History
| DATE | FREE CASH FLOW YIELD |
|---|---|
| 2026-06-11 | 3.20% |
| 2026-06-10 | 3.26% |
| 2026-06-09 | 3.18% |
| 2026-06-08 | 3.21% |
| 2026-06-05 | 3.14% |
| 2026-06-04 | 3.21% |
| 2026-06-03 | 3.31% |
| 2026-06-02 | 3.29% |
| 2026-06-01 | 3.25% |
| 2026-05-29 | 3.14% |
| 2026-05-28 | 3.15% |
| 2026-05-27 | 3.14% |
| 2026-05-26 | 3.12% |
| 2026-05-22 | 3.12% |
| 2026-05-21 | 3.08% |
| 2026-05-20 | 3.11% |
| 2026-05-19 | 3.16% |
| 2026-05-18 | 3.17% |
| 2026-05-15 | 3.21% |
| 2026-05-14 | 3.15% |
| 2026-05-13 | 3.11% |
| 2026-05-12 | 3.16% |
| 2026-05-11 | 3.21% |
| 2026-05-08 | 3.19% |
| 2026-05-07 | 3.20% |
| 2026-05-06 | 3.16% |
| 2026-05-05 | 3.22% |
| 2026-05-04 | 3.18% |
| 2026-05-01 | 3.16% |
| 2026-04-30 | 3.11% |
| 2026-04-29 | 3.15% |
| 2026-04-28 | 3.63% |
| 2026-04-27 | 3.61% |
| 2026-04-24 | 3.57% |
| 2026-04-23 | 3.52% |
| 2026-04-22 | 3.47% |
| 2026-04-21 | 3.46% |
| 2026-04-20 | 3.37% |
| 2026-04-17 | 3.30% |
| 2026-04-16 | 3.38% |
| 2026-04-15 | 3.36% |
| 2026-04-14 | 3.31% |
| 2026-04-13 | 3.35% |
| 2026-04-10 | 3.32% |
| 2026-04-09 | 3.30% |
| 2026-04-08 | 3.31% |
| 2026-04-07 | 3.37% |
| 2026-04-06 | 3.34% |
| 2026-04-02 | 3.33% |
| 2026-04-01 | 3.37% |
| 2026-03-31 | 3.43% |
| 2026-03-30 | 3.49% |
| 2026-03-27 | 3.59% |
| 2026-03-26 | 3.69% |
| 2026-03-25 | 3.62% |
| 2026-03-24 | 3.64% |
| 2026-03-23 | 3.68% |
| 2026-03-20 | 3.69% |
| 2026-03-19 | 3.58% |
| 2026-03-18 | 3.59% |
| 2026-03-17 | 3.54% |
| 2026-03-16 | 3.52% |
| 2026-03-13 | 3.56% |
| 2026-03-12 | 3.52% |
| 2026-03-11 | 3.50% |
| 2026-03-10 | 3.47% |
| 2026-03-09 | 3.47% |
| 2026-03-06 | 3.48% |
| 2026-03-05 | 3.43% |
| 2026-03-04 | 3.36% |
| 2026-03-03 | 3.35% |
| 2026-03-02 | 3.32% |
| 2026-02-27 | 3.25% |
| 2026-02-26 | 3.32% |
| 2026-02-25 | 3.29% |
| 2026-02-24 | 3.28% |
| 2026-02-23 | 3.48% |
| 2026-02-20 | 3.50% |
| 2026-02-19 | 3.42% |
| 2026-02-18 | 3.42% |
| 2026-02-17 | 3.41% |
| 2026-02-13 | 3.47% |
| 2026-02-12 | 3.49% |
| 2026-02-11 | 3.49% |
| 2026-02-10 | 3.70% |
| 2026-02-09 | 3.80% |
| 2026-02-06 | 3.70% |
| 2026-02-05 | 3.82% |
| 2026-02-04 | 3.81% |
| 2026-02-03 | 3.87% |
| 2026-02-02 | 3.79% |
| 2026-01-30 | 3.82% |
| 2026-01-29 | 3.90% |
| 2026-01-28 | 3.80% |
| 2026-01-27 | 3.80% |
| 2026-01-26 | 3.99% |
| 2026-01-23 | 4.02% |
| 2026-01-22 | 3.98% |
| 2026-01-21 | 4.08% |
| 2026-01-20 | 3.90% |
| 2026-01-16 | 3.74% |
| 2026-01-15 | 3.78% |
| 2026-01-14 | 3.75% |
| 2026-01-13 | 3.79% |
| 2026-01-12 | 3.85% |
| 2026-01-09 | 3.74% |
| 2026-01-08 | 3.79% |
| 2026-01-07 | 3.74% |
| 2026-01-06 | 3.75% |
| 2026-01-05 | 3.99% |
| 2026-01-02 | 3.91% |
| 2025-12-31 | 4.07% |
| 2025-12-30 | 3.95% |
| 2025-12-29 | 3.82% |
| 2025-12-26 | 3.94% |
| 2025-12-24 | 3.83% |
| 2025-12-23 | 3.90% |
| 2025-12-22 | 3.95% |
| 2025-12-19 | 3.94% |
| 2025-12-18 | 3.96% |
| 2025-12-17 | 3.87% |
| 2025-12-16 | 3.91% |
| 2025-12-15 | 3.88% |
| 2025-12-12 | 3.97% |
| 2025-12-11 | 3.95% |
| 2025-12-10 | 3.92% |
| 2025-12-09 | 3.99% |
| 2025-12-08 | 3.95% |
| 2025-12-05 | 3.98% |
| 2025-12-04 | 3.97% |
| 2025-12-03 | 3.90% |
| 2025-12-02 | 3.99% |
| 2025-12-01 | 3.96% |
| 2025-11-28 | 3.89% |
| 2025-11-26 | 3.79% |
| 2025-11-25 | 3.80% |
| 2025-11-24 | 3.91% |
| 2025-11-21 | 3.91% |
| 2025-11-20 | 4.01% |
| 2025-11-19 | 3.97% |
| 2025-11-18 | 4.08% |
| 2025-11-17 | 4.07% |
| 2025-11-14 | 4.08% |
| 2025-11-13 | 4.02% |
| 2025-11-12 | 4.07% |
| 2025-11-11 | 4.08% |
| 2025-11-10 | 4.08% |
| 2025-11-07 | 4.30% |
| 2025-11-06 | 4.22% |
| 2025-11-05 | 3.45% |
| 2025-11-04 | 3.39% |
| 2025-11-03 | 3.46% |
| 2025-10-31 | 3.40% |
| 2025-10-30 | 3.40% |
| 2025-10-29 | 3.42% |
| 2025-10-28 | 3.38% |
| 2025-10-27 | 3.41% |
| 2025-10-24 | 3.42% |
| 2025-10-23 | 3.33% |
| 2025-10-22 | 3.35% |
| 2025-10-21 | 3.33% |
| 2025-10-20 | 3.35% |
| 2025-10-17 | 3.27% |
| 2025-10-16 | 3.31% |
| 2025-10-15 | 3.33% |
| 2025-10-14 | 3.31% |
| 2025-10-13 | 3.31% |
| 2025-10-10 | 3.30% |
| 2025-10-09 | 3.29% |
| 2025-10-08 | 3.25% |
| 2025-10-07 | 3.29% |
| 2025-10-06 | 3.25% |
| 2025-10-03 | 3.28% |
| 2025-10-02 | 3.40% |
| 2025-10-01 | 3.44% |
| 2025-09-30 | 3.74% |
| 2025-09-29 | 3.83% |
| 2025-09-26 | 3.83% |
| 2025-09-25 | 3.74% |
| 2025-09-24 | 3.76% |
| 2025-09-23 | 3.71% |
| 2025-09-22 | 3.57% |
| 2025-09-19 | 3.62% |
| 2025-09-18 | 3.65% |
| 2025-09-17 | 3.59% |
| 2025-09-16 | 3.66% |
| 2025-09-15 | 3.62% |
| 2025-09-12 | 3.51% |
| 2025-09-11 | 3.45% |
| 2025-09-10 | 3.49% |
| 2025-09-09 | 3.49% |
| 2025-09-08 | 3.43% |
| 2025-09-05 | 3.40% |
| 2025-09-04 | 3.45% |
| 2025-09-03 | 3.45% |
| 2025-09-02 | 3.48% |
| 2025-08-29 | 3.47% |
| 2025-08-28 | 3.54% |
| 2025-08-27 | 3.48% |
| 2025-08-26 | 3.49% |
| 2025-08-25 | 3.43% |
| 2025-08-22 | 3.56% |
| 2025-08-21 | 3.48% |
| 2025-08-20 | 3.55% |
| 2025-08-19 | 3.52% |
| 2025-08-18 | 3.49% |
| 2025-08-15 | 3.60% |
| 2025-08-14 | 3.59% |
| 2025-08-13 | 3.63% |
| 2025-08-12 | 3.77% |
| 2025-08-11 | 3.83% |
| 2025-08-08 | 3.95% |
| 2025-08-07 | 3.80% |
| 2025-08-06 | 3.76% |
| 2025-08-05 | 3.72% |
| 2025-08-04 | 3.72% |
| 2025-08-01 | 3.79% |
| 2025-07-31 | 3.80% |
| 2025-07-30 | 3.59% |
| 2025-07-29 | 3.72% |
| 2025-07-28 | 4.30% |
| 2025-07-25 | 4.27% |
| 2025-07-24 | 4.22% |
| 2025-07-23 | 4.21% |
| 2025-07-22 | 4.37% |
| 2025-07-21 | 4.44% |
| 2025-07-18 | 4.51% |
| 2025-07-17 | 4.48% |
| 2025-07-16 | 4.36% |
| 2025-07-15 | 4.42% |
| 2025-07-14 | 4.33% |
| 2025-07-11 | 4.42% |
| 2025-07-10 | 4.32% |
| 2025-07-09 | 4.38% |
| 2025-07-08 | 4.42% |
| 2025-07-07 | 4.35% |
| 2025-07-03 | 4.41% |
| 2025-07-02 | 4.31% |
| 2025-07-01 | 4.44% |
| 2025-06-30 | 4.44% |
| 2025-06-27 | 4.49% |
| 2025-06-26 | 4.43% |
| 2025-06-25 | 4.24% |
| 2025-06-24 | 4.39% |
| 2025-06-23 | 4.36% |
| 2025-06-20 | 4.44% |
| 2025-06-18 | 4.32% |
| 2025-06-17 | 4.40% |
| 2025-06-16 | 4.18% |
| 2025-06-13 | 4.19% |
| 2025-06-12 | 4.13% |
| 2025-06-11 | 4.18% |
| 2025-06-10 | 4.23% |
| 2025-06-09 | 4.23% |
| 2025-06-06 | 4.30% |
| 2025-06-05 | 4.34% |
| 2025-06-04 | 4.26% |
| 2025-06-03 | 4.35% |
| 2025-06-02 | 4.35% |
| 2025-05-30 | 4.38% |
Showing the most recent 260 of 4,927 data points. The chart above shows the full history.
About AstraZeneca PLC
AstraZeneca PLC operates as a global biopharmaceutical leader, dedicated to the entire process of bringing prescription medicines to market, from their initial discovery and development through manufacturing and commercialization. The company's extensive portfolio of treatments, including prominent examples like Tagrisso, Farxiga, and Symbicort, addresses critical areas such as cardiovascular, renal, metabolic, and oncological conditions. Furthermore, it provides essential solutions for COVID-19 and various rare diseases, with products like Vaxzevria and Soliris. AstraZeneca engages with primary and specialty care physicians worldwide, facilitating distribution through a robust network of representatives and local offices across the United Kingdom, continental Europe, the Americas, Asia, Africa, and Australasia. The firm actively drives innovation through strategic collaborations, partnering with entities such as Neurimmune AG for the development and commercialization of NI006, BenevolentAI for systemic lupus erythematosus drug discovery, Lunit for AI-powered digital pathology risk assessment in NSCLC, and Absci Corporation for AI-driven oncology target identification. Founded in 1992, the company was initially known as Zeneca Group PLC, subsequently rebranding to AstraZeneca PLC in April 1999, and maintains its headquarters in Cambridge, United Kingdom.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Pascal Claude Roland Soriot